Celgene-backed cancer biotech Repare emerges from stealth with $68M
Fierce Biotech,
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an…
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an…
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an…
March 30th, 2017 Xconomy Boston — As the understanding of cancer advances, scientists are discovering built-in features of the…